Journal of Agricultural and Food Chemistry · 2021 · 75 citations · 31 references
PharmacyBotanyPlant SciencesDrug DiscoveryMycologyStructure-activity RelationshipsAntifungal AgentsFungal Secondary MetabolitesLead Compound DesignMedicinal PlantsNatural Product Drug DiscoveryNatural Product-based Drug DesignBotanical FungicidesFungal Bioactive CompoundsFungal Drug DiscoveryNatural Antifungal CompoundsNew Antifungal AgentsQuinoline AlkaloidsQuinoline ChemistryQuinoline Synthesis
Enlightened from our previous work of structural simplification of quinine and innovative application of natural products against phytopathogenic fungi, lead structure 2,8-bis(trifluoromethyl)-4-quinolinol (3) was selected to be a candidate and its diversified design, synthesis, and antifungal evaluation were carried out. All of the synthesized compounds Aa1–Db1 were evaluated for their antifungal activity against four agriculturally important fungi, Botrytis cinerea, Fusarium graminearum, Rhizoctonia solani, and Sclerotinia sclerotiorum. Results showed that compounds Ac3, Ac4, Ac7, Ac9, Ac12, Bb1, Bb10, Bb11, Bb13, Cb1. and Cb3 exhibited a good antifungal effect, especially Ac12 had the most potent activity with EC50 values of 0.52 and 0.50 μg/mL against S. sclerotiorum and B. cinerea, respectively, which were more potent than those of the lead compound 3 (1.72 and 1.89 μg/mL) and commercial fungicides azoxystrobin (both >30 μg/mL) and 8-hydroxyquinoline (2.12 and 5.28 μg/mL). Moreover, compound Ac12 displayed excellent in vivo antifungal activity, which was comparable in activity to the commercial fungicide boscalid. The preliminary mechanism revealed that compound Ac12 might cause an abnormal morphology of cell membranes, an increase in membrane permeability, and release of cellular contents. These results indicated that compound Ac12 displayed superior in vitro and in vivo fungicidal activities and could be a potential fungicidal candidate against plant fungal diseases.
31
Yield Trends Are Insufficient to Double Global Crop Production by 2050
D. K. Ray, Nathaniel D. Mueller, Paul West et al. · PLoS ONE · 2013 · 3.4K citations · Full text
Pei Li, Li Shi, Xia Yang et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 146 citations